Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001762951-26-000004
Filing Date
2026-03-03
Accepted
2026-03-03 18:10:06
Documents
1
Period of Report
2026-02-27

Document Format Files

Seq Description Document Type Size
1 form4-03032026_060301.html 4  
1 form4-03032026_060301.xml 4 3167
  Complete submission text file 0001762951-26-000004.txt   4541
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Issuer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address
Donoghoe Nicholas (Reporting) CIK: 0001762951 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35565 | Film No.: 26717311